Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP212098.RAg_zR-wgkD9-vzopoo_PyG415OjP0crlD_VdU8ThQHtA130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212098.RAg_zR-wgkD9-vzopoo_PyG415OjP0crlD_VdU8ThQHtA130_provenance.
• NP510889.RApIEr7_FP3btTjx-Ur64NTAhgSWGiwAj9PnAfsD0dA78130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510889.RApIEr7_FP3btTjx-Ur64NTAhgSWGiwAj9PnAfsD0dA78130_provenance.
• NP282292.RAhAtTXS9vC62FYgbD3BBpIUixMK3_-sOUlMEtQanZEyQ130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282292.RAhAtTXS9vC62FYgbD3BBpIUixMK3_-sOUlMEtQanZEyQ130_provenance.
• NP441901.RAZsiK4JihaPJGw9C-K1uGBB5vuKdIjLYCmJ7gIWhJX_M130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441901.RAZsiK4JihaPJGw9C-K1uGBB5vuKdIjLYCmJ7gIWhJX_M130_provenance.
• NP894824.RAzcLW-03OBNeP1J_1xVxDc5XsbfSHx_ubwzc02jwgPwo130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894824.RAzcLW-03OBNeP1J_1xVxDc5XsbfSHx_ubwzc02jwgPwo130_provenance.
• NP818793.RAYIMgBbADMFH76MjPRSNq0o8GaoWApAtwN-hb1itqGDs130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818793.RAYIMgBbADMFH76MjPRSNq0o8GaoWApAtwN-hb1itqGDs130_provenance.
• NP904340.RAa9ePX37YXX0ThFGJ3LNkWdk02AGGCgtTzM0FOr3LKNo130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904340.RAa9ePX37YXX0ThFGJ3LNkWdk02AGGCgtTzM0FOr3LKNo130_provenance.
• NP582374.RAPU-MglEf9qZIz28nBqESNTCnxuy6yKmZGP0laFhsmDk130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582374.RAPU-MglEf9qZIz28nBqESNTCnxuy6yKmZGP0laFhsmDk130_provenance.
• NP1024595.RAXWBRXcsr8h_lMbI9Bz0IvktYO6mz5fJmlTfsjKpHPWk130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024595.RAXWBRXcsr8h_lMbI9Bz0IvktYO6mz5fJmlTfsjKpHPWk130_provenance.
• NP818922.RAjFjmD5tcxxdIDtgdr65xHd1SQN-swIopKmopHzLeWow130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818922.RAjFjmD5tcxxdIDtgdr65xHd1SQN-swIopKmopHzLeWow130_provenance.
• NP817966.RAHpm-qRYC_ncB3fuBJwcatK15DNy82LaxDtukHPptVIg130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817966.RAHpm-qRYC_ncB3fuBJwcatK15DNy82LaxDtukHPptVIg130_provenance.
• NP904257.RAkUjrwJZD3-eRBEWFx1F3zHtd-71qhriZShYkFLWWdg4130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904257.RAkUjrwJZD3-eRBEWFx1F3zHtd-71qhriZShYkFLWWdg4130_provenance.
• NP904385.RAvrurizNeKRfLh5gTEOYFU2kwWFLzU_gGcFzb8AizLPc130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904385.RAvrurizNeKRfLh5gTEOYFU2kwWFLzU_gGcFzb8AizLPc130_provenance.
• NP1024602.RAnf68jMi-XTGKCNaXCz0YTAuwWNldwIiTgIFJ2ew199Y130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024602.RAnf68jMi-XTGKCNaXCz0YTAuwWNldwIiTgIFJ2ew199Y130_provenance.
• NP818912.RAF92zWlfcWDdM8pjNT6mGJlfvAm3syFo_qa6PLaupkDs130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818912.RAF92zWlfcWDdM8pjNT6mGJlfvAm3syFo_qa6PLaupkDs130_provenance.
• NP818878.RA07qoDLGzSfD_9gSGOS3t5BdrKeeSpK3qqcPZZs9a5w4130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818878.RA07qoDLGzSfD_9gSGOS3t5BdrKeeSpK3qqcPZZs9a5w4130_provenance.
• NP904375.RA36FzJeEWXAvNw_yZ2j7NU_9C4nUlhtKKkht6MTi3MzY130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904375.RA36FzJeEWXAvNw_yZ2j7NU_9C4nUlhtKKkht6MTi3MzY130_provenance.
• NP1024597.RA8Jd2Ya7Fke4jEb62i4VnRTDbdJN3W7GUVTrNn182EOg130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024597.RA8Jd2Ya7Fke4jEb62i4VnRTDbdJN3W7GUVTrNn182EOg130_provenance.
• NP1024599.RA6VMkqfWpO4oXyRQDYYgf4ucioKUMptjLHT55z_3-TJk130_assertion description "[These results suggest that MSC-TRAIL is sufficiently effective in inhibiting MFH-ino metastasis and the application using MSC-TRAIL could be extended to other sarcomas and recurrent metastatic cancers for cell-mediated cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024599.RA6VMkqfWpO4oXyRQDYYgf4ucioKUMptjLHT55z_3-TJk130_provenance.